Schlagwort: startseite1

The patient perspective is important in all medical research, and particularly in drug development. This is reflected in the European research initiative PREFER in which a research group at Universitätsklinikum Erlangen is involved.

A study shows a new, surprising role played by blood vessels: under certain conditions they can inhibit tumour growth.

Researchers at FAU working together with colleagues from Freie Universität Berlin have discovered a new molecule: the iron compound in the rare oxidation state +4 belongs to the ferrocenes and is exceptionally difficult to synthesise.

Websites can retrieve information on visitors’ browser characteristics without their knowledge or consent. What many aren’t aware of: the combination of these characteristics is generally unique, making users identifiable.

Around 400,000 people in Germany suffer from chronic inflammatory bowel disease. Researchers at Universitätsklinikum Erlangen have recently published findings showing that a special technique can improve the examination procedure for the disease.

FAU's position among the world's top universities has been confirmed once again in the latest list by the Center for World University Rankings, which puts FAU at number 194 internationally.

Over the next three years, researchers at FAU will build the PEER Lab technology and transfer centre in which high-performance electronic modules are developed, optimised and tested for their reliability.

FAU stands for innovation:In Reuters' latest ranking of Europe's most innovative universities, FAU is ranked at number 6.

The Italian and French consuls general have visited FAU President Prof. Dr. Joachim Hornegger and signed the University's Golden Book.

FAU has performed excellently again in the Centre for Higher Education’s (CHE) university ranking, and is ranked among the best for chemistry and for electrical engineering and information engineering.